ApprovalTrail

Approval · Notice of Compliance 3632 · 2004

IMAVEROL CONCENTRATED SOLUTION: Notice of Compliance 3632

Issued May 19, 2004

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
3632
Date
May 19, 2004
Company
Merial Canada Inc.Burlington, Ontario, Canada
Product type
Veterinary
Submission
New Drug Submission (NDS)
Submission class
Other
Therapeutic class
Antimycotic

Products in this notice

BrandDINStatus today
IMAVEROL CONCENTRATED SOLUTION00768685Marketed

Medicinal ingredients